A corrigendum to this notice was published on 26 March 2019, Notice No. 2019-go1373.

Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:

Dosage Form:

New Zealand Sponsor:
Manufacturer:

MEDIX Nasal Inhaler
Camphor 394mg/mL
Menthol 394mg/mL
Volatile liquid for inhalation
Nova Pharmaceuticals NZ Limited
Makson Industries Private Limited, Gummadidala Mandal, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

NYXOID
Naloxone hydrochloride dihydrate 2.2mg equivalent to naloxone 1.8mg per 100mL
Nasal spray solution
Mundipharma New Zealand Limited
Summit Biosciences LLC, Kentucky, United States of America

Dated this 15th day of March 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).